Cetuximab in Neoadjuvant Treatment of Non-Resectable Colorectal Liver Metastases (CELIM)
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
General Objectives:
- To test the feasibility of neoadjuvant treatment with cetuximab/chemotherapy followed by
liver resection
- To determine the optimal combination (cetuximab/FOLFOX versus cetuximab/FOLFIRI) for
further trials in preoperative chemotherapy